Oncology Brothers

Lung Cancers Today

<p>In this insightful episode, The Oncology Brothers are joined by Dr. Eric Singhi, Assistant Professor – University of Texas, MD Anderson Cancer Center, to discuss a treatment algorithm for metastatic non-small cell lung cancer without targetable mutations in the first-line setting.</p>


Stephen V. Liu, MD

Cecilia Brown

ASCO 2025 Update on CheckMate 816: Stephen Liu, MD, Shares Insights

ASCO 2025

Jorge Nieva, MD

Should Immunotherapy Be Administered Earlier in the Day? Thoracic Oncologist Weights in on New ASCO 2025 Data

FDA Grants Accelerated Approval to Datopotamab Deruxtecan for EGFR-Positive NSCLC

EGFR+ NSCLC

Triparna Sen, PhD

Countering Immune Evasion in SCLC: Triparna Sen, PhD, Shares Insights on Drivers of MHC Repression

FDA Approval of Taletrectinib for ROS1+ NSCLC: Dr. Liu Weighs In

Non-Small Cell Lung Cancer

Jennifer W. Carlisle, MD

How a Team Implemented Outpatient Administration of Tarlatamab for SCLC

Latest News

Assessing an Algorithm for Metastatic Non-Small Cell Lung Cancer Without Targetable Mutations

In this insightful episode, The Oncology Brothers are joined by Dr. Eric Singhi, Assistant Professor - University of ...